Plain-English translation of NCT06530927 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying tiny blood clots and activated immune cells found in the blood of stroke patients. By examining blood samples under advanced microscopes, they hope to discover whether these cells and clots can predict stroke risk and whether a patient's treatment will be successful. This study involves 500 patients at various stages of stroke — some with recent strokes, some with past strokes, and healthy volunteers without stroke history.
Even when doctors successfully reopen blocked blood vessels in stroke patients using current treatments, about 40–50% of patients still have severe disability because tiny clots block blood flow in smaller vessels. Researchers believe that understanding these micro-clots and immune cell changes could help predict treatment failure and eventually lead to better outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this study, doctors will take blood samples from you, likely at the time of your hospital admission and possibly at follow-up visits. If you undergo a mechanical thrombectomy procedure (a catheter-based treatment to remove the clot), the doctors will also analyze the clot that is removed. The study team will use advanced microscopes to examine your blood samples for tiny clots and activated immune cells. You will be compared to other stroke patients who received different treatments and to a healthy control group without stroke history.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Switzerland